M. W. Davis

A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients.

E. Shpall, T. Shea, G. Long, 1999, Blood.

Pharmacokinetics and Colchicine in Pediatric and Adult Patients with Familial Mediterranean Fever

E. Ben-Chetrit, S. Ozen, S. Wason, 2012, International journal of immunopathology and pharmacology.

A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

J. Gabrilove, A. Nakanishi, J. Kurtzberg, 1993, Blood.

Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor.

J. Glaspy, S. Scates, R. Roberts, 1991, American journal of diseases of children.

Biology and clinical potential of stem-cell factor

J. Glaspy, I. Mcniece, M. Foote, 1996, Cancer Chemotherapy and Pharmacology.

Treatment of rheumatoid arthritis with PEGylated recombinant human soluble tumour necrosis factor receptor type I: a clinical update

Steven W. Martin, C. Edwards, A. Bendele, 2000, Annals of the rheumatic diseases.